Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.

Scandinavian journal of immunology - 1 Sept 2020

Zhang Xiaofei, Wang Shaojun, Ding Xueli, Guo Jing, Tian Zibin

Abstract excerpt

Inflammatory bowel diseases (IBD) are a group of chronic recurrent gastrointestinal inflammatory diseases, including ulcerative colitis (UC), Crohn's disease (CD) and IBD unclassified. The pathogenesis may be related to the mucosal immune dysfunction in genetically susceptible hosts affected by environmental factors. Current therapeutic agents mainly include aminosalicylates, corticosteroids, immunosuppressive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Engineering

Share to Inflammatory Bowel Diseases

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Organ Specificity

Share to Transplantation Conditioning

Source

Identifiers

PMID: 32443180
DOI: 10.1111/sji.12897

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.PMID 32443180Read ↗

Stem Cell-Based Therapies for Inflammatory Bowel DiseaseSemantic proximity Read ↗

Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.Semantic proximity Read ↗

Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease.Semantic proximity Read ↗

Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology.Semantic proximity Read ↗

Insights into Modeling Inflammatory Bowel Disease from Stem Cell Derived Intestinal OrganoidsSemantic proximity Read ↗

Mesenchymal stem cells ameliorate inflammation in an experimental model of Crohn’s disease via the mesenterySemantic proximity Read ↗

Umbilical cord mesenchymal stem cells in ulcerative colitis treatment: efficacy and possible mechanismsSemantic proximity Read ↗

Mesenchymal stem cells—the master immunomodulatorsSemantic proximity Read ↗

The effects of mesenchymal stem cells on the chemotherapy of colorectal cancerSemantic proximity Read ↗

Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.Semantic proximity Read ↗

Stem cells as treatment in inflammatory bowel disease.Semantic proximity Read ↗

Mesenchymal stromal/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damageSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.